Compile Data Set for Download or QSAR
maximum 50k data
Found 19 Enz. Inhib. hit(s) with all data for entry = 1913
TargetGenome polyprotein(Hepatitis C Virus (Virus))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM347076(US10202403, Compound 1001)
Affinity DataEC50:  2.08E+3nMAssay Description:An on-bead solid phase homogeneous assay was used in a 384-well format to assess NS5B inhibitors (WangY-K, Rigat K, Roberts S, and Gao M (2006) Anal ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C Virus (Virus))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM347095(US10202403, Compound 2005)
Affinity DataEC50:  931nMAssay Description:An on-bead solid phase homogeneous assay was used in a 384-well format to assess NS5B inhibitors (WangY-K, Rigat K, Roberts S, and Gao M (2006) Anal ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C Virus (Virus))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM347078(US10202403, Compound 1003)
Affinity DataEC50:  2.84E+3nMAssay Description:An on-bead solid phase homogeneous assay was used in a 384-well format to assess NS5B inhibitors (WangY-K, Rigat K, Roberts S, and Gao M (2006) Anal ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C Virus (Virus))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM347079(US10202403, Compound 1004)
Affinity DataEC50: >1.00E+4nMAssay Description:An on-bead solid phase homogeneous assay was used in a 384-well format to assess NS5B inhibitors (WangY-K, Rigat K, Roberts S, and Gao M (2006) Anal ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C Virus (Virus))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM347080(US10202403, Compound 1005)
Affinity DataEC50: >1.00E+4nMAssay Description:An on-bead solid phase homogeneous assay was used in a 384-well format to assess NS5B inhibitors (WangY-K, Rigat K, Roberts S, and Gao M (2006) Anal ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C Virus (Virus))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM347081(US10202403, Compound 1006)
Affinity DataEC50: >1.00E+4nMAssay Description:An on-bead solid phase homogeneous assay was used in a 384-well format to assess NS5B inhibitors (WangY-K, Rigat K, Roberts S, and Gao M (2006) Anal ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C Virus (Virus))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM347082(US10202403, Compound 1007)
Affinity DataEC50:  1.29E+3nMAssay Description:An on-bead solid phase homogeneous assay was used in a 384-well format to assess NS5B inhibitors (WangY-K, Rigat K, Roberts S, and Gao M (2006) Anal ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C Virus (Virus))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM347083(US10202403, Compound 1008)
Affinity DataEC50:  1.82E+3nMAssay Description:An on-bead solid phase homogeneous assay was used in a 384-well format to assess NS5B inhibitors (WangY-K, Rigat K, Roberts S, and Gao M (2006) Anal ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C Virus (Virus))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM347084(US10202403, Compound 1009)
Affinity DataEC50:  2.08E+3nMAssay Description:An on-bead solid phase homogeneous assay was used in a 384-well format to assess NS5B inhibitors (WangY-K, Rigat K, Roberts S, and Gao M (2006) Anal ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C Virus (Virus))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM347085(US10202403, Compound 1010 | US10202403, Compound 1...)
Affinity DataEC50:  1.63E+3nMAssay Description:An on-bead solid phase homogeneous assay was used in a 384-well format to assess NS5B inhibitors (WangY-K, Rigat K, Roberts S, and Gao M (2006) Anal ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C Virus (Virus))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM347085(US10202403, Compound 1010 | US10202403, Compound 1...)
Affinity DataEC50:  1.09E+3nMAssay Description:An on-bead solid phase homogeneous assay was used in a 384-well format to assess NS5B inhibitors (WangY-K, Rigat K, Roberts S, and Gao M (2006) Anal ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C Virus (Virus))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM347087(US10202403, Compound 1012)
Affinity DataEC50:  530nMAssay Description:An on-bead solid phase homogeneous assay was used in a 384-well format to assess NS5B inhibitors (WangY-K, Rigat K, Roberts S, and Gao M (2006) Anal ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C Virus (Virus))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM347088(US10202403, Compound 1013)
Affinity DataEC50:  1.51E+3nMAssay Description:An on-bead solid phase homogeneous assay was used in a 384-well format to assess NS5B inhibitors (WangY-K, Rigat K, Roberts S, and Gao M (2006) Anal ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C Virus (Virus))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM347089(US10202403, Compound 1014)
Affinity DataEC50: >1.00E+4nMAssay Description:An on-bead solid phase homogeneous assay was used in a 384-well format to assess NS5B inhibitors (WangY-K, Rigat K, Roberts S, and Gao M (2006) Anal ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C Virus (Virus))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM347090(US10202403, Compound 1015)
Affinity DataEC50: >1.00E+4nMAssay Description:An on-bead solid phase homogeneous assay was used in a 384-well format to assess NS5B inhibitors (WangY-K, Rigat K, Roberts S, and Gao M (2006) Anal ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C Virus (Virus))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM347091(US10202403, Compound 2001)
Affinity DataEC50:  6.67E+3nMAssay Description:An on-bead solid phase homogeneous assay was used in a 384-well format to assess NS5B inhibitors (WangY-K, Rigat K, Roberts S, and Gao M (2006) Anal ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C Virus (Virus))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM347093(US10202403, Compound 2002)
Affinity DataEC50:  3.65E+3nMAssay Description:An on-bead solid phase homogeneous assay was used in a 384-well format to assess NS5B inhibitors (WangY-K, Rigat K, Roberts S, and Gao M (2006) Anal ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C Virus (Virus))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM347094(US10202403, Compound 2004)
Affinity DataEC50: >1.00E+4nMAssay Description:An on-bead solid phase homogeneous assay was used in a 384-well format to assess NS5B inhibitors (WangY-K, Rigat K, Roberts S, and Gao M (2006) Anal ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C Virus (Virus))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM347077(US10202403, Compound 1002)
Affinity DataEC50:  672nMAssay Description:An on-bead solid phase homogeneous assay was used in a 384-well format to assess NS5B inhibitors (WangY-K, Rigat K, Roberts S, and Gao M (2006) Anal ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent